Privi Speciality Chemicals (PRIVISCL) Q1 24/25 earnings summary

Executive summary

• Achieved 13% year-over-year revenue growth in Q1 FY25, driven by improved product mix and higher capacity utilization.

• EBITDA rose 60% year-over-year to Rs 97 crore, reflecting operational efficiency and market share gains.

• Board approved unaudited standalone and consolidated financial results for the quarter ended June 30, 2024.

• Statutory auditors issued an unmodified review conclusion for both standalone and consolidated results.

• Investment of 26% equity through a Special Purpose Vehicle for a solar power project was approved, pending final terms.

Financial highlights

• Q1 FY25 revenue: Rs 467 crore, up 13% year-over-year; EBITDA: Rs 97 crore (20.8% margin), up 60%; PAT: Rs 31 crore (6.7% margin), up 598%.

• EPS for Q1 FY25 at Rs 8.05, compared to Rs 1.15 in Q1 FY24.

• Standalone revenue from operations was ₹44,116.43 lakhs, up from ₹40,513.83 lakhs year-over-year.

• Standalone net profit for the quarter was ₹3,221.46 lakhs, compared to ₹497.12 lakhs in the same quarter last year.

• Consolidated revenue from operations was ₹46,397.56 lakhs, up from ₹40,872.18 lakhs year-over-year.

Outlook and guidance

• JV with Givaudan to start operations in Q3 FY25, expected to add Rs 150 crore in potential revenue.

• Board approved investment in a solar power project, indicating a focus on sustainability and future cost management.

• Focus on ramping up new product capacities and launching additional products, including menthol and peppermint oil.

• Continued emphasis on sustainability, operational efficiency, and expanding global footprint.